Awareness and perception of thromboembolism and thromboprophylaxis among hospitalized patients in Jordan.
Despite the established importance of thromboprophylaxis in patients with Venous Thromboembolism (VTE), limited number of studies has assessed the awareness of VTE and the thromboprophylaxis therapy among the affected patients. The aim of the current study was to assess awareness and to explore variables associated with awareness about VTE and its thromboprophylaxis. Setting and Method: A cross-sectional study was conducted on hospitalized patients who had received thromboprophylaxis (5000 units of heparin subcutaneously (SC) q8-12 h, or 30-40 mg of enoxaparin SC once daily). In addition to the sociodemographic variables, awareness and perception about VTE and its thromboprophylaxis were assessed using a validated questionnaire. Multiple logistic regressions were conducted to build a model of variables significantly associated with VTE awareness. Predictors of awareness about VTE and its thromboprophylaxis. A total of 225 patients participated in the study, with only 38.2% and 22.2% of the participants were aware of deep vein thrombosis (DVT) and pulmonary embolism (PE) respectively. Logistic regression showed that the participants with low educational level were 3.046 the odds being not aware of DVT or PE compared with participants with high education level. Participants without a personal history of VTE were 7.374 the odds being not aware of DVT or PE compared with those who had a personal history of VTE. Participants who had a negative perception of VTE were 2.582 the odds being not aware of DVT or PE compared with participants who had a positive perception and those who had not received information about DVT or PE were 13.727 the odds being not aware of DVT or PE. The findings reveal that there is a lack of awareness about VTE and its thromboprophylaxis among the study participants. Patients with lower educational level and those with no history of previous VTE need awareness improvement about VTE and its thromboprophylaxis. Clinical Pharmacists need to focus on providing information about VTE and improving patients' perception about VTE and its thromboprophylaxis with the aim of improving the awareness about VTE, and hence improve health outcome.